Clinician-Guided Tirzepatide Therapy

Itemized quote before enrollment

Personalized Tirzepatide

$0to start

A weekly dual-action GLP-1 + GIP injection for appetite regulation support when clinically appropriate.

GLP-1 + GIP (Tirzepatide)
Dual-pathway weekly support.
GLP-1 (Semaglutide)
Weekly GLP-1 pathway.
All plans include:
✓
Licensed clinician evaluation
✓
Secure patient portal access
✓
Refill review & coordination
✓
Discreet home delivery

Licensed U.S. providers, qualified pharmacy fulfillment, and clear pricing before you enroll — with flexibility to change or cancel per your program terms.

Starting at:
$0 to start · Itemized quote before enrollment

Final price depends on prescribed therapy, dosage, pharmacy, shipping, and state. All charges and recurring terms are shown before enrollment.

See if I qualify

Dual pathways.One provider-guided protocol.

Tirzepatide activates GLP-1 and GIP receptors — supporting appetite regulation through a broader metabolic signal when your Nexa Rx clinician determines it is appropriate.

Dual receptor support for appetite regulation.

Tirzepatide works on GLP-1 and GIP pathways — designed for patients who may benefit from stronger appetite and metabolic signaling.

Structured titration with clinical oversight.

Dosing starts low and increases gradually under licensed provider review — giving your body time to adapt safely.

Built around your response — not a template.

Your care team adjusts the protocol based on how you respond, with secure messaging and refill review included in active care.

Check Eligibility

Nexa Rx · Personalized Tirzepatide · GLP-1 + GIP

A dual-action
approach to weight
management.

Tirzepatide activates both GLP-1 and GIP receptors for stronger appetite regulation and a broader metabolic response when medically appropriate.

At Nexa Rx, your dosing protocol is reviewed and prescribed by a licensed U.S. provider, then adjusted as you progress — with clear pricing before enrollment.

What to expect, week by week with your GLP-1 treatment

No guesswork. Here's how the first months typically look for patients in the program. Individual experiences vary.

Week 1 → 4 · Your body is adjusting

You start on a low dose — intentionally. Your treatment is introduced gradually so your body can adapt. Some patients notice appetite changes early; others take a few more weeks. Both are normal. Your clinician is available throughout.

Week 4 → 12 · The protocol starts to settle

As titration continues, your clinician monitors how you respond. Appetite signals and dosing may be adjusted based on your individual course — experiences vary, and treatment is not guaranteed to produce a specific outcome.

Month 3+ · Calibrated to you

Your clinician fine-tunes your plan with real precision based on your response. The focus shifts from adjustment to consistency, and maintainable progress becomes the rhythm.

Before you begin

Straight answers before you enroll.

Clinical review, pricing, and delivery — the questions patients ask most before starting GLP-1 + GIP (Tirzepatide).

  • Tirzepatide is a dual GLP-1/GIP receptor agonist that may be prescribed for chronic weight management when medically appropriate. Nexa Rx connects you with licensed clinicians for evaluation and ongoing support.

Care blueprint

Everything included in your Tirzepatide program

Program highlights

  • Dual-action GLP-1/GIP therapy evaluated by a licensed clinician
  • FDA-approved brand options or compounded tirzepatide when clinically appropriate
  • Ongoing titration support, refill coordination, and transparent pricing before enrollment

Ongoing care

  • Follow-up: Licensed clinician review via secure messaging, typically within 2 business days.
  • Refills: Refill review every 30 days when clinically appropriate.
  • Labs: Baseline labs when indicated; follow-up labs every 3–6 months based on your care plan.
  • Messaging: Clinical messaging included in the active program.

Medication status

  • Tirzepatide activates both GLP-1 and GIP receptors and may be prescribed for chronic weight management when medically appropriate.
  • Your clinician may prescribe FDA-approved products (such as Zepbound or Mounjaro, when indicated) or compounded tirzepatide where legally available.
  • Dosing, titration, and formulation follow your clinician’s plan — preference alone does not determine treatment.

The Nexa Rx difference

Why Nexa Rx?

Provider-guided Semaglutide & Tirzepatide — designed with clinical clarity, not checkout chaos.

01

Transparent & trusted

From compounding partners to doorstep delivery — pharmaceutical-grade quality with clear, clinical oversight.

  • Quality sourcing503A pharmacies
  • Medical reviewLicensed U.S. providers
  • Home deliveryDiscreet & expedited

LegitScript certification — pending review · not yet verified

02

Care built around you

Semaglutide or Tirzepatide — protocols tailored to your goals, history, and how your body responds.

  • Medical intakeClinical questionnaire first
  • Provider decisionPrescribe only if appropriate
  • Ongoing titrationDose adjusted as needed
03

Science-backed GLP-1

Weekly protocols guided by licensed clinicians for appetite regulation support — not guaranteed outcomes.

04

Support within reach

Your portal, care team, and treatment plan — organized in one place whenever you need them.

Start Tirzepatide with licensed clinical guidance

Clear pricing before enrollment. Discreet delivery when prescribed.

Check Eligibility

GLP-1 therapies require medical evaluation and a valid prescription. Compounded semaglutide and tirzepatide are not FDA-approved as finished branded products when dispensed in compounded form.

State availability

Broad availability across the U.S. with state-specific prescribing and pharmacy rules.

View full state matrix →

Check Eligibility